Four drug companies — Agomab Therapeutics, Eikon Therapeutics, Spyglass Pharma, and Veradermics — went public this week, ...
Sustained interest in small molecules, bispecific antibodies, and genomics got the ball rolling in the biotech deals arena in ...
Investor's Business Daily on MSN
China biotech lights up. US stocks prepare for a new powerhouse.
U.S.-based biotech stocks are closely watching the China's rapid advance into the biotech field. Will they withstand the ...
Biotech investors often chase early-stage companies in the hope that a single breakthrough trial will deliver massive returns ...
Feb 4 (Reuters) - Biotech firm PrimeGen US will go public in the United States through a $1.5 billion deal with blank-check ...
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ('Kelun-Biotech' or the 'Company', 6990.HK) announced that a new indication application for its TROP2-directed ADC sacituzumab tirumotecan (sac-TMT, ...
The confluence of China’s rapidly rising biotech prowess and US policy decisions that hamper the industry is a cause for ...
The latest firm to top up its venture capital coffers is Austin, Texas-based Santé Ventures, which on Monday announced its ...
The companies Aktis Oncology, Alumis, and Parabilis Medicines bagged the biggest biotech funding rounds overall in January ...
Eikon Therapeutics increased the size of its initial public offering at the last minute and priced at the top of its range, ...
Life sciences leaders in Boston are increasingly concerned that the "millionaires tax" is driving away founders and investors ...
Investing.com -- Oncolytics Biotech Inc (NASDAQ:ONCY) stock surged 16.2% Wednesday after the FDA granted Fast Track Designation for its pelareorep therapy in colorectal cancer treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results